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Abstract 
 
      A total of 51 cases of bovine clinical mastitis in Sulaimani district were investigated for their bacteriological causative 
agents; 76 milk samples were cultured on primary and selective media and the isolated bacteria were tested for their 
susceptibility to antimicrobial agents used in commercial intramammary infusion products. Eighty two bacterial isolates 
were obtained and further identified using biochemical tests. Escherichia coli was the most common bacteria followed by 
Staphylococcus  aureus,  Streptococcus  agalactia  and  coagulase–negative  staphylococci.  Two  other  bacterial  species 
(Pseudomonas  aeruginosa    and  Streptococcucs  uberis)  were  also  isolated  but  in  a  lower  proportion.  Antibacterial 
susceptibility testing showed that the use of florfenicol, cephalexin and gentamicin may be useful for the treatment of 
clinical mastitis cases in cows. 
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Introduction  
 
Bovine  mastitis  is  the  most  costly  disease  facing  the 
dairy  industry  throughout  the  world.  It  creates  estimated 
losses of about two billions dollars per year in the United 
States (1). The majority of losses is due to reduced milk 
production, production of lower quality milk, cost of drugs 
and veterinary services, increased culling rate and reduced 
reproductive efficiency (2). 
Mastitis  or  intramammary  infection  can  generally  be 
classified as clinical and subclinical (3) Clinical mastitis is 
characterized by an abnormal secretion containing clots or 
flakes  (4,  5).  Sudden  onset  of  clinical  mastitis  (acute 
clinical mastitis) is accompanied by swelling, hardness and 
increased temperature and it also may be accompanied by 
systemic signs such as loss of appetite, fever, dehydration, 
or depression (6).  
No apparent changes in the udder or milk are expected 
with subclinical mastitis, although microorganisms can be 
isolated by  appropriate  culture techniques.  Compositional 
changes and increased somatic cell count in milk usually 
accompany  subclinical  mastitis  and  can  be  detected  by 
appropriate tests (3, 7). 
Many of intramammary infections originate during the 
dry  or  nonlactating  period  and  result  in  clinical  or 
subclinical  mastitis  during  early  lactation  (4).  More  than 
135  different  microorganisms  have  been  isolated  from 
bovine  intramammary  infections  (3).  The  causative 
organisms  of  mastitis  are  categorized  as  contagious 
pathogens including Staphylococcus aureus, Streptococcus 
agalactia,  and  Mycoplasma  bovis  or  as  environmental 
pathogens  such  as  environmental      streptococci  (e.g., 
Streptococcus dysagalactia and Streptococcus uberis), and 
the  enterobacteriaceae  (8-10).  Coagulase–negative 
staphylococci,  which  colonize  bovine  teat  skin  and  teat 
canals, are classed as skin flora opportunists (3).  
Rapid  reduction  in  herd  mastitis  level  requires 
identification  of  infected  glands  and  specific  pathogens, 
followed by drug therapy and/or culling of affected cows. 
Thus, microbiological culturing is the single most reliable 
tool for developing a specific mastitis control program for a 
dairy herd (3, 11). 
The objectives of this study were to isolate and identify 
mastitis  associated  bacteria  in  Sulaimani  district  and  to 
determine  the  susceptibility  of  the  isolated  bacteria  to 
antimicrobial  agents  used  in  commercial  intramammary 
infusion products. 
 
Materials and Methods 
 
Sample collection 
      A total of 51 individual clinical cases of bovine mastitis 
were investigated from July 2003 through August 2006 at 
the teaching veterinary hospital and at several small private 
cattle herds in Sulaimani district.     
Milk samples were collected from 76 mastitic quarters 
which  were  recognized  by  swelling,  hardness,  warmth 
and/or abnormal secretions (abnormal color or consistency 
and/or presence of clots or flacks). Sampling of milk was 
performed according to Watts, (3) as below: 
•  The  udder  was  carefully  washed,  dried  and  several 
streams of milk were forcibly stripped from the mastitic 
quarter.  The  teat  of  the  affected  quarter  was  then 
scrubbed with a cotton pledget soaked in 70% alcohol.   
•  Two streams of milk were collected into a sterile screw 
capped vials. 
•  Collected samples were immediately kept in an insulated 
container  with  ice  packs  and  transferred  to  the 
laboratory for bacterial culturing. 
 
Bacterial Isolation and identification 
     Milk  samples  were  brought  to  room  temperature  and 
mixed thoroughly. A 0.1 ml of each sample was surface 
plated  on  5%  calf  blood  agar,  MacConkey’s  agar  and 
nutrient agar. 
      The  inoculated  plates  were  subsequently  incubated 
aerobically at 37°C and examined for growth after 16 to 48 
hours of incubation. 
      Primary cultures were evaluated by visual examination 
of  the  morphology  of  the  bacterial  colonies  and  were 
subcultured  on  mannitol  salt  agar,  eosin  methylene  blue 
agar and nutrient agar slants. 
      Identification  of  the  purified  bacterial  cultures  was 
applied using conventional bacteriological and biochemical 
procedures as described by Carter and Carter et al. (12 and 
13) as well as commercial identification kits including the 
enterosystem 18R (Liofilchem s.r.l., Italy) and the Analytic 
Profile Index -API- (Biomériux, France). 
      Cultures  were  considered  to  be  negative  when  no 
bacterial  growth  was  observed  on  the  culture  plates  and 
they were considered to be positive when only one or two 
species of bacteria, known to cause mastitis, were isolated 
from  a  sample  or  when  contagious  pathogens  such  as 
Staphylococcus  aureus  or  Streptoococcus  agalactia  were 
recovered, even in a mixture of environmental bacteria. On 
the other hand, cultures were considered to be contaminated 
when  they  show  mixed  growth  of  three  or  more 
environmental bacteria (11). 
 
Susceptibility testing 
     The Bauer Kirby procedure (14), on Muller–Hinton agar 
plates  was  used  to  determine  the  susceptibility  of  the 
bacterial  isolates  that  obtained  in  the  present  study  to 
antimicrobial  agents  used  in  commercial  intramammary 
infusion  products  such  as  ampicillin,  cephalexin, Iraqi Journal of Veterinary Sciences, Vol. 22, No. 1, 2008 (35-41) 
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erythromycin,  florfenicol,  gentamicin,    penicillin, 
streptomycin, and tetracycline.  
      Following 16-18 hours of aerobic incubation, the plates 
were examined and the diameter of the zone of inhibition 
was  measured  by  a  ruler.  The  zone  diameters  were 
expressed as resistant, intermediate or susceptible according 
to Chengappa (15). 
 
Results and Discussion 
  
      The identification of etiological agents of mastitis along 
with  their  susceptibility  or  resistance  to  antimicrobial 
agents used in intramammary infusion products, may help 
in  controlling  bovine  mastitis,  one  of  the  most  costly 
diseases  affecting  the  dairy  industry,  and  in  developing 
therapy protocols for particular dairy farms (11).  To our 
knowledge, this is the first investigation of clinical mastitis 
cases in cattles in Sulaimani district. 
      Of the seventy six milk samples examined in the present 
study,  six  samples  revealed  negative  cultures  and  eleven 
samples  revealed  mixed  cultures  of  three  or  more 
environmental  bacteria  and  accordingly  considered 
contaminated. The remaining 59 samples revealed positive 
cultures  of  which,  23  samples  showed  dual  bacterial 
isolation, i. e., a total of 82 different bacterial isolates were 
recovered and the biochemical tests revealed these isolates 
belong to 7 species. The isolation frequency of the bacterial 
strains  and  their  responses  to  the  most  important 
biochemical  tests  are  summarized  in  table  1  and  2 
respectively.  
The  high  prevalence  of  Escherichia  coli–induced 
clinical  mastitis  encountered  in  the  present  study  is  in 
agreement with the findings of other authors (16-18) who 
considered  the  Escherichia  coli  organisms  as  major 
etiological  agents  of  clinical  mastitis.  They  are 
opportunistic  environmental  or  enteric  pathogens  and  it 
may  be  possible  for  the  infected  quarter  to  serve  as 
reservoir for recurrent episodes of Escherichia coli–induced 
clinical mastitis (19,20). It is worth mentioning that cases of 
Escherichia coli–induced clinical mastitis are often of very 
short  duration  and  milk  samples  may  reveal  negative 
cultures  in  approximately  20%  of  such  cases  (11,16), 
accordingly,  the  six  culture–negative  milk  samples 
encountered in the present study may be attributed either to 
Escherichia coli or to other intramammary pathogens could 
not be detected in the present study such as Mycoplasma 
species. 
      Staphylococcus  aureus  and  Streptococcus  agalactia–
induced clinical mastitis cases were also encountered in a 
high  prevalence  in  this  study.  This  finding  is  similar  to 
those of other authors (4, 21,22). However, it disagrees with 
findings of some other authors (6,23) who mentioned that 
these  two  bacteria  are  currently  classified  as  causes  of 
subclinical rather than clinical mastitis. This disagreement 
can  be  attributed  to  the  poor  mastitis  control  measures 
applied in Sulaimani district wherein, cattle breeding is of 
the semi–intensive type and management of animals is the 
whole  family  duty  especially  females  who  have  little  or 
even  no  idea  about  the  principle  concepts  of  animal 
management  compared  to  the  effective  control  measures 
followed  in  dairy  herds  of  the  developed  countries. 
Nevertheless  Staphylococcus  aureus  and  Streptococcus 
agalactia  are  considered  significant  organisms  associated 
with clinical and subclinical bovine mastitis worldwide (9, 
10,  13  and  24)  due  to  persistent  cow  –to–  cow  spread, 
possibly via milking machines and perhaps by the hands of 
milkers (25). Their main reservoirs are infected quarters (3, 
26). In addition, Staphylococcus aureus can also be isolated 
from the skin of the udder and teats and from many other 
sites in dairy cows as well as feed and caretakers (27, 28). 
      The  other  bacterial  species  frequently  isolated  in  the 
present  study  are  coagulase–negative  staphylococci 
including Staphylococcus epidermidis and Staphylococcus 
xylosus. The importance of such bacterial species as a cause 
of  clinical  mastitis  has  come  under increased scrutiny  in 
dairy  herds  used  effective  recommended  mastitis  control 
measures,  they  were  previously  considered  as  mastitis 
minor  pathogens  associated  with  a  mild  inflammatory 
reaction but they are now known to cause clinical mastitis 
(29, 30). They colonize bovine teat skin and teat canals, 
thus they are classed as skin flora opportunists (3).  
Other bacteria including Pseudomonas aeroginosa and 
Streptococcus  uberis  were  also  isolated  from  mastitic 
quarters  milk  but  in  a  lower  proportion  compared  with 
those  mentioned  above  (table  1).  These  findings  are 
generally in agreement with those reported by other authors 
(4, 21, 22). 
The  natural  habitat  of  Pseudomonas  aeruginosa 
organisms is water, soil, and decaying vegetation; they also 
may be found on the skin and mucous membranes, and in 
feces, thus they are classified as environmental mammary 
gland pathogens (13). 
Streptococcus uberis is classified as an environmental 
mammary gland pathogen; it colonizes various body sites 
including  teat  canal  and  has  been  isolated  from  bedding 
material. (3).  
The susceptibility of the bacterial species isolated in the 
present  study  to  the  antimicrobial  agents  used  in 
commercial intramammary  infusion products  is shown in 
table 3. These results are generally in agreement with the 
findings of other authors (3, 11, 13, 31). They showed that 
except  Pseudomonas  aeruginosa,  all  bacterial  isolates 
obtained in the present study were susceptible or at least 
intermediately susceptible to florfenicol and cephalexin. In 
addition, the Escherichia coli isolates were also susceptible 
or intermediately susceptible to ampicillin, gentamicin and 
streptomycin;  the  Staphylococcus  isolates  were 
intermediately susceptible to erythromycin, gentamicin, and Iraqi Journal of Veterinary Sciences, Vol. 22, No. 1, 2008 (35-41) 
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streptomycin;  and  the  streptococcal  isolates  showed  high 
susceptibility to penicillin G, ampicillin, and erythromycin.  
 Regarding  the  Pseudomonas  aeruginosa  isolates,  they 
were  resistant to  most  antibacterial  agents; however they 
showed  moderate  susceptibility  to  gentamicin.  Thus,  the 
simultaneous use of florfenicol, cephalexin and gentamicin 
may be useful for the treatment of bovine clinical mastitis 
cases in Sulaimani district. 
 
Table 1: Bacterial isolates from milk samples obtained from the mastitic quarters. 
 
Bacteria  Number of isolates  %* 
Escherichia coli  31  37.8 
Staphylococcus aureus  19  23.2 
Streptococcucs agalactia  15  18.3 
Staphylococcus epidermidis  9  10.98 
Staphylococcus xylosus  3  3.66 
Pseudomonas aeruginosa  3  3.7 
Streptococcucs uberis  2  2.4 
Total  82   
* The percentage is with respect to the total number of isolates (82). 
 
 
Table 2: The biochemical properties of the bacterial isolates obtained from milk samples of  mastitic quarters. 
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Escherichia coli  +  +  –  –   –   *      α ,β    –  V  V  +  +  +    –  V 
Staphylococcus aureus             –   +   +    β  +   –   –     +   +  +       
Streptococcucs agalactia             –   –   –  α ,β           +   +   –      – 
Staphylococcus epidermidis             –   –   +    –  +   –   –     +   +   –       
Staphylococcus xylosus             –   –   +    –  +   –   –     +   +   +   +   +  + 
Pseudomonas aeruginosa   –         –   +        β  +   +   –   –   –   –       +   
Streptococcucs uberis             –   –   –    α            +   +   +      + 
 * : not tested; V: Variable 
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Table 3: Antimicrobial susceptibility testing of the bacterial isolates obtained in the present   study to the antimicrobial agents 
used in commercial intramammary infusion product. 
 
Inhibition  zone  diameter * 
Resistant  Intermediate  Susceptible 
 
 
Antimicrobial 
agent 
 
Disk potency  Diameter 
" mm " 
No. of 
isolates 
Diameter 
" mm " 
No. of 
isolates 
Diameter 
" mm " 
No. of 
isolates 
Ampicillin 
 Escherichia coli  
 Staphylococcus  aureus   
 Streptococcus agalactia 
 
 
10 µg 
10 µg 
10 µg 
 
 
≤ 11 
≤ 28 
≤ 21 
 
 
2 
19 
__ 
 
12 – 13 
__ ** 
__ ** 
 
7 
__ 
__ 
 
≥ 14 
≥ 29 
≥ 30 
 
22 
__ 
15 
Cephalexin 
 Escherichia coli  
 Staphylococcus  aureus   
 Streptococcus agalactia 
 
 
30 µg 
30 µg 
30 µg 
 
 
≤ 14 
≤ 14 
≤ 14 
 
 
5 
__ 
__ 
 
15 – 17 
15 – 17 
15 – 17 
 
14 
5 
2 
 
≥ 18 
≥ 18 
≥ 18 
 
 
12 
14 
13 
Erythromycin 
 Escherichia coli  
 Staphylococcus  aureus   
 Streptococcus agalactia 
 
 
15 µg 
15 µg 
15 µg 
 
 
≤ 13 
≤ 13 
≤ 13 
 
 
28 
4 
__ 
 
14 – 17 
14 – 17 
14 – 17 
 
3 
9 
5 
 
≥ 18 
≥ 18 
≥ 18 
 
 
__ 
6 
10 
Florfenicol 
 Escherichia coli  
 Staphylococcus  aureus   
 Streptococcus agalactia 
 
 
30 µg 
30 µg 
30 µg 
 
 
≤ 12 
≤ 12 
≤ 12 
 
__ 
2 
3 
 
13 – 17 
13 – 17 
13 – 17 
 
10 
5 
5 
 
≥ 18 
≥ 18 
≥ 18 
 
21 
12 
7 
Gentamicin 
 Escherichia coli 
Staphylococcus  aureus 
Streptococcus agalactia 
 
10 µg 
10 µg 
10 µg 
 
 
≤ 12 
≤ 12 
≤ 12 
 
 
4 
3 
15 
 
13 – 14 
13 – 14 
13 – 14 
 
9 
8 
__ 
 
≥ 15 
≥ 15 
≥ 15 
 
 
18 
8 
__ 
Penicillin G *** 
  Escherichia coli  
Staphylococcus  aureus 
Streptococcus agalactia  
 
10 U 
10 U 
10 U 
 
 
≤ 11 
≤ 20 
≤ 11 
 
 
28 
16 
__ 
 
 
12 – 21 
21 – 28 
12 – 21 
 
3 
3 
__ 
 
≥ 22 
≥ 29 
≥ 22 
 
 
__ 
__ 
15 
Streptomycin 
Escherichia coli 
    Staphylococcus  aureus   
    Streptococcus agalactia 
 
10 µg 
10 µg 
10 µg 
 
 
≤ 11 
≤ 11 
≤ 11 
 
 
7 
5 
15 
 
12 – 14 
12 – 14 
12 – 14 
 
13 
8 
__ 
 
≥ 15 
≥ 15 
≥ 15 
 
 
11 
6 
__ 
Tetracycline 
    Escherichia coli  
    Staphylococcus  aureus   
    Streptococcus agalactia 
 
30 µg 
30 µg 
30 µg 
 
 
≤ 14 
≤ 14 
≤ 14 
 
 
26 
17 
3 
 
15 – 18 
15 – 18 
15 – 18 
 
5 
2 
7 
 
≥ 19 
≥ 19 
≥ 19 
 
__ 
__ 
5 
*  The interpretive standards of the inhibition zone diameter in this table are mentioned according to Chengappa, 1990 (15). 
 **   Not available or not recommended.  
 *** Benzyl-penicillin. 
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Table 3. (continued) 
 
Inhibition  zone  diameter * 
Resistant  Intermediate  Susceptible 
 
 
Antimicrobial 
agent 
 
Disk potency  Diameter 
" mm " 
No. of 
isolates 
Diameter 
" mm " 
No. of 
isolates 
Diameter 
" mm " 
No. of 
isolates 
Ampicillin 
Coagulase – negative  
staphylococci  
Pseudomonas aeruginosa 
Streptococcus uberis 
 
 
10 µg 
10 µg 
10 µg 
 
 
≤ 28 
≤ 11 
≤ 21 
 
 
9 
3 
__ 
 
 
__ ** 
12 – 13 
  __ ** 
 
 
__ 
__ 
__ 
 
 
≥ 29 
≥ 14 
≥ 30 
 
 
3 
__ 
2 
Cephalexin 
 Coagulase – negative 
staphylococci  
Pseudomonas aeruginosa 
 Streptococcus uberis 
 
 
30 µg 
30 µg 
30 µg 
 
 
≤ 14 
≤ 14 
≤ 14 
 
 
__ 
3 
__ 
 
 
15 – 17 
15 – 17 
15 – 17 
 
 
4 
__ 
__ 
 
 
≥ 18 
≥ 18 
≥ 18 
 
 
8 
__ 
2 
Erythromycin 
Coagulase – negative 
staphylococci  
Pseudomonas aeruginosa 
Streptococcus uberis 
 
 
15 µg 
15 µg 
15 µg 
 
 
≤ 13 
≤ 13 
≤ 13 
 
 
4 
3 
__ 
 
 
 14 – 17 
 14 – 17 
 14 – 17 
 
 
3 
__ 
__ 
 
 
≥ 18 
≥ 18 
≥ 18 
 
 
5 
__ 
2 
Florfenicol 
Coagulasen – negative 
staphylococci  
Pseudomonas aeruginosa 
Streptococcus uberis 
 
 
30 µg 
30 µg 
30 µg 
 
 
≤ 12 
≤ 12 
≤ 12 
 
 
__ 
3 
__ 
 
 
 13 – 17 
 13 – 17 
 13 – 17 
 
 
2 
__ 
__ 
 
 
≥ 18 
≥ 18 
≥ 18 
 
 
10 
__ 
2 
Gentamicin 
 Coagulase – negative 
staphylococci  
Pseudomonas aeruginosa 
Streptococcus uberis 
 
 
 
10 µg 
10 µg 
10 µg 
 
 
≤ 12 
≤ 12 
≤ 12 
 
 
1 
__ 
2 
 
 
13 – 14 
13 – 14 
13 – 14 
 
 
8 
3 
__ 
 
 
≥ 15 
≥ 15 
≥ 15 
 
 
3 
__ 
__ 
Penicillin G  *** 
 Coagulase – negative 
staphylococci  
Pseudomonas aeruginosa 
Streptococcus uberis 
 
 
10 U 
10 U 
10 U 
 
 
≤ 20 
≤ 11 
≤ 11 
 
 
9 
3 
__ 
 
 
21 – 28 
12 – 21 
12 – 21 
 
 
__ 
__ 
__ 
 
 
≥ 29 
≥ 22 
≥ 22 
 
 
3 
__ 
2 
Streptomycin 
Coagulase – negative 
staphylococci  
Pseudomonas aeruginosa 
Streptococcus uberis 
 
 
10 µg 
10 µg 
10 µg 
 
 
≤ 11 
≤ 11 
≤ 11 
 
 
3 
1 
2 
 
 
12 – 14 
12 – 14 
12 – 14 
 
 
5 
2 
__ 
 
 
≥ 15 
≥ 15 
≥ 15 
 
 
4 
__ 
__ 
Tetracycline 
Coagulase – negative 
staphylococci  
Pseudomonas aeruginosa 
Streptococcus uberis 
 
 
30 µg 
30 µg 
30 µg 
 
 
≤ 14 
≤ 14 
≤ 14 
 
 
8 
3 
__ 
 
 
15 – 18 
15 – 18 
15 – 18 
 
 
1 
__ 
1 
 
 
≥ 19 
≥ 19 
≥ 19 
 
 
3 
__ 
1 
*  The interpretive standards of the inhibition zone diameter in this table are mentioned according to Chengappa, 1990 (15). 
    **   Not available or not recommended.  
    *** Benzyl-penicillin. 
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